Morgan Stanley Reiterates Equal-Weight, Raises Price Target On Haemonetics As Emerging FY16 Stability Brings Search For Upside

By: via Benzinga
In a report published Monday, Morgan Stanley analyst James Francescone reiterated an Equal-Weight rating on Haemonetics Corporation ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.